BJ
ALPN icon

BlackRock Japan’s Alpine Immune Sciences Inc ALPN Stock Holding History

BlackRock Japan’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Sell
384
-18
-4% -$359 ﹤0.01% 1278
2016
Q3 		$13K Sell
402
-297
-42% -$7.23K ﹤0.01% 1184
2016
Q2 		$13K Buy
699
+534
+324% +$9.48K ﹤0.01% 1244
2016
Q1 		$3K Buy
+165
New +$3.3K ﹤0.01% 1398

Other funds holding ALPN

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Japan's ALPN Position: Q4 2016 in Review

BlackRock Japan reduced its Alpine Immune Sciences Inc (ALPN) stake by 4.5% in Q4 2016, selling an estimated $359 and leaving 384 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

BlackRock Japan first reported a position in ALPN in Q1 2016 and has held it in 4 quarters since. The position peaked at $13K in Q3 2016. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • BlackRock Japan held 384 shares of Alpine Immune Sciences Inc worth $3K as of Q4 2016.
  • BlackRock Japan sold 18 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $359.
  • Alpine Immune Sciences Inc made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1278 holding.
  • BlackRock Japan first reported a position in Alpine Immune Sciences Inc in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Japan's Alpine Immune Sciences Inc position peaked at $13K in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.